We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+3.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.13B
AUM Growth
+$508M
Cap. Flow
+$450M
Cap. Flow %
10.89%
Top 10 Hldgs %
28.06%
Holding
5,776
New
587
Increased
2,247
Reduced
2,253
Closed
660

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$135M
2
MSFT icon
Microsoft
MSFT
+$75.2M
3
NVDA icon
NVIDIA
NVDA
+$68.1M
4
AMZN icon
Amazon
AMZN
+$62.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$58.9M

Sector Composition

Rank Sector Weight
1 Technology 29.75%
2 Communication Services 9.71%
3 Consumer Discretionary 9.03%
4 Financials 8.48%
5 Healthcare 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
3701
Tvardi Therapeutics
TVRD
$22.1M
$10.8K ﹤0.01%
2,509
+2,158
+615% +$19.3K
AFYA icon
3702
Afya
AFYA
$1.23B
$10.8K ﹤0.01%
+700
New +$10.3K
ILPT
3703
Industrial Logistics Properties Trust
ILPT
$611M
$10.8K ﹤0.01%
1,947
-563
-22% -$3.11K
BSET icon
3704
Bassett Furniture
BSET
$170M
$10.8K ﹤0.01%
643
-107
-14% -$1.68K
AMRN
3705
Amarin Corp
AMRN
$299M
$10.8K ﹤0.01%
772
-199
-20% -$3.28K
RM icon
3706
Regional Management Corp
RM
$301M
$10.8K ﹤0.01%
278
-143
-34% -$5.53K
EPM icon
3707
Evolution Petroleum
EPM
$135M
$10.8K ﹤0.01%
3,039
+218
+8% +$920
SMID icon
3708
Smith-Midland
SMID
$147M
$10.8K ﹤0.01%
296
-233
-44% -$8.36K
GLUE icon
3709
Monte Rosa Therapeutics
GLUE
$1.35B
$10.8K ﹤0.01%
686
-2,757
-80% -$37.2K
ISPR icon
3710
Ispire Technology
ISPR
$91.3M
$10.8K ﹤0.01%
3,841
-580
-13% -$1.35K
VYGR icon
3711
Voyager Therapeutics
VYGR
$198M
$10.8K ﹤0.01%
2,736
-7,371
-73% -$32.6K
ATYR
3712
aTyr Pharma
ATYR
$54.2M
$10.8K ﹤0.01%
13,729
-20,105
-59% -$16.5K
ADV icon
3713
Advantage Solutions
ADV
$423M
$10.7K ﹤0.01%
489
+201
+70% +$5.81K
KLTR icon
3714
Kaltura
KLTR
$243M
$10.7K ﹤0.01%
6,549
-1,215
-16% -$1.92K
KGEI
3715
Kolibri Global Energy
KGEI
$200M
$10.7K ﹤0.01%
2,730
+491
+22% +$2.14K
EHTH icon
3716
eHealth
EHTH
$38.8M
$10.7K ﹤0.01%
2,332
-409
-15% -$1.8K
SGC icon
3717
Superior Group of Companies
SGC
$210M
$10.7K ﹤0.01%
1,107
+64
+6% +$625
FRBA icon
3718
First Bank
FRBA
$471M
$10.7K ﹤0.01%
651
-168
-21% -$2.69K
PAMT
3719
PAMT Corp
PAMT
$285M
$10.7K ﹤0.01%
887
-64
-7% -$678
NVCT icon
3720
Nuvectis Pharma
NVCT
$627M
$10.7K ﹤0.01%
1,418
-2,431
-63% -$15.8K
RGNX icon
3721
Regenxbio
RGNX
$704M
$10.7K ﹤0.01%
743
-2,708
-78% -$33.8K
TTEC icon
3722
TTEC Holdings
TTEC
$77.4M
$10.7K ﹤0.01%
2,970
-542
-15% -$1.84K
CBK
3723
Commercial Bancgroup
CBK
$485M
$10.7K ﹤0.01%
+435
New +$10.7K
FUNC icon
3724
First United
FUNC
$298M
$10.7K ﹤0.01%
285
-145
-34% -$5.39K
FENC icon
3725
Fennec Pharmaceuticals
FENC
$423M
$10.7K ﹤0.01%
1,384
-240
-15% -$1.97K

Similar funds

Tower Research Capital (TRC)'s Q4 2025 Portfolio in Review

As of Q4 2025, Tower Research Capital (TRC) held 5,776 positions worth $4.13B, up 14% from $3.62B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Tower Research Capital (TRC) deployed $450M of net new capital in Q4 2025, opening 587 new positions and adding to 2,247 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 139,132 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 17% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $431M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2025 buy was iShares 20+ Year Treasury Bond ETF: 139,132 shares worth $12.1M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2025, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $431M.
  • Tower Research Capital (TRC) fully exited iShares 0-3 Month Treasury Bond ETF in Q4 2025, selling an estimated $25.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 28% of its $4.13B portfolio in Q4 2025.
  • Tower Research Capital (TRC) opened 587 new positions and closed 660 in Q4 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 14% quarter-over-quarter to $4.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.